ClinicalTrials.gg

Program

KL0011034

A development code. Also written as “KL0011034 injection”.

Its studies are mostly in Chronic Pain, led by Sichuan Kelun Pharmaceutical.

Furthest: phase 1, since Feb 24, 20264 company-led studies, 3 open or runningNext primary completion: Nov 24, 2026 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Sichuan Kelun Pharmaceutical43 open or runningphase 1since Feb 24, 2026Feb 24, 2026Nov 24, 2026phase 1 · NCT07913048

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Feb 24, 2026First study: phase 1 study in Healthy VolunteersFirst studyNCT07474545 · 76 planned · China
  2. Jul 5, 2026Phase 1 study in Chronic PainNCT07710560 · 27 enrolled · China
  3. Sep 11, 2026Phase 1 study in Healthy VolunteersNCT07828470 · 30 planned · China
  4. Oct 28, 2026Phase 1 study in Healthy ParticipantsNCT07913048 · 20 planned · China

Ahead

  1. Nov 13, 2026Primary completion: phase 1 study in Healthy VolunteersNCT07828470
  2. Nov 24, 2026Primary completion: phase 1 study in Healthy ParticipantsNCT07913048
  3. Dec 31, 2027Primary completion: phase 1 study in Healthy VolunteersNCT07474545

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07913048Healthy Participants · China1Not yet recruitingNov 24, 202620
NCT07828470Healthy Volunteers · China1Not yet recruitingNov 13, 202630
NCT07710560Chronic Pain · China1CompletedAug 12, 202627
NCT07474545Healthy Volunteers · China1RecruitingDec 31, 202776

How it is read

Names in the registry

  • “KL0011034 injection”, 4 entries

Codes read as this program: KL0011034.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.